BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31355797)

  • 21. Functional determination of the differentiation potential of ventral mesencephalic neural precursor cells during dopaminergic neurogenesis.
    Guerrero-Flores G; Bastidas-Ponce A; Collazo-Navarrete O; Guerra-Crespo M; Covarrubias L
    Dev Biol; 2017 Sep; 429(1):56-70. PubMed ID: 28733161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells into Dopaminergic Neurons.
    Daadi MM
    Methods Mol Biol; 2019; 1919():89-96. PubMed ID: 30656623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
    Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
    Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.
    Grow DA; Simmons DV; Gomez JA; Wanat MJ; McCarrey JR; Paladini CA; Navara CS
    Stem Cells Transl Med; 2016 Sep; 5(9):1133-44. PubMed ID: 27343168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence.
    Winiecka-Klimek M; Smolarz M; Walczak MP; Zieba J; Hulas-Bigoszewska K; Kmieciak B; Piaskowski S; Rieske P; Grzela DP; Stoczynska-Fidelus E
    PLoS One; 2015; 10(11):e0141688. PubMed ID: 26535892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
    Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
    EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.
    Lehnen D; Barral S; Cardoso T; Grealish S; Heuer A; Smiyakin A; Kirkeby A; Kollet J; Cremer H; Parmar M; Bosio A; Knöbel S
    Stem Cell Reports; 2017 Oct; 9(4):1207-1220. PubMed ID: 28943253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.
    Suzuki S; Akamatsu W; Kisa F; Sone T; Ishikawa KI; Kuzumaki N; Katayama H; Miyawaki A; Hattori N; Okano H
    Biochem Biophys Res Commun; 2017 Jan; 483(1):88-93. PubMed ID: 28057485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
    Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
    Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications.
    He XB; Yi SH; Rhee YH; Kim H; Han YM; Lee SH; Lee H; Park CH; Lee YS; Richardson E; Kim BW; Lee SH
    Stem Cells; 2011 Nov; 29(11):1861-73. PubMed ID: 21922608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midbrain Dopaminergic Neurons Differentiated from Human-Induced Pluripotent Stem Cells.
    Tofoli FA; Semeano ATS; Oliveira-Giacomelli Á; Gonçalves MCB; Ferrari MFR; Veiga Pereira L; Ulrich H
    Methods Mol Biol; 2019; 1919():97-118. PubMed ID: 30656624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct and selective lineage conversion of human fibroblasts to dopaminergic precursors.
    He M; Zhang H; Li Y; Tian C; Tang B; Huang Y; Zheng J
    Neurosci Lett; 2019 Apr; 699():16-23. PubMed ID: 30664902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Nurr1 in the Generation and Differentiation of Dopaminergic Neurons from Stem Cells.
    Rodríguez-Traver E; Solís O; Díaz-Guerra E; Ortiz Ó; Vergaño-Vera E; Méndez-Gómez HR; García-Sanz P; Moratalla R; Vicario-Abejón C
    Neurotox Res; 2016 Jul; 30(1):14-31. PubMed ID: 26678495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts.
    Kim J; Su SC; Wang H; Cheng AW; Cassady JP; Lodato MA; Lengner CJ; Chung CY; Dawlaty MM; Tsai LH; Jaenisch R
    Cell Stem Cell; 2011 Nov; 9(5):413-9. PubMed ID: 22019014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease.
    Gonzalez R; Garitaonandia I; Poustovoitov M; Abramihina T; McEntire C; Culp B; Attwood J; Noskov A; Christiansen-Weber T; Khater M; Mora-Castilla S; To C; Crain A; Sherman G; Semechkin A; Laurent LC; Elsworth JD; Sladek J; Snyder EY; Redmond DE; Kern RA
    Cell Transplant; 2016 Nov; 25(11):1945-1966. PubMed ID: 27213850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic activation of the Foxa2 gene is required for maintaining the potential of neural precursor cells to differentiate into dopaminergic neurons after expansion.
    Bang SY; Kwon SH; Yi SH; Yi SA; Park EK; Lee JC; Jang CG; You JS; Lee SH; Han JW
    Stem Cells Dev; 2015 Feb; 24(4):520-33. PubMed ID: 25233056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct Reprogramming of Human Fetal- and Stem Cell-Derived Glial Progenitor Cells into Midbrain Dopaminergic Neurons.
    Nolbrant S; Giacomoni J; Hoban DB; Bruzelius A; Birtele M; Chandler-Militello D; Pereira M; Ottosson DR; Goldman SA; Parmar M
    Stem Cell Reports; 2020 Oct; 15(4):869-882. PubMed ID: 32976765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.